SCHEMBL9515843

SCHEMBL9515843

O=C(NS(=O)(=O)CC(O)c1ccc(F)cc1F)c1ccc(CO)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
HDAC6 Q9UBN7 3/20 0.39
APLNR P35414 2/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KLKB1 P03952 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HTT P42858 1/20 0.35
P4HTM Q9NXG6 3/20 0.35
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517189 0.90 LMNA (0.39) LMNAPOLBHDAC6APLNRNPC1
SCHEMBL9515528 0.89 LMNA (0.38) LMNAPOLBHDAC6APLNRNPC1
SCHEMBL9515678 0.87 APLNR (0.40) LMNAPOLBHDAC6APLNRNPC1
SCHEMBL9516327 0.86 APLNR (0.39) LMNAPOLBHDAC6APLNRNPC1
SCHEMBL9516945 0.86 LMNA (0.40) LMNAPOLBHDAC6APLNRNPC1
SCHEMBL9518022 0.85 HDAC6 (0.39) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9517030 0.83 SLC6A9 (0.39) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9515835 0.80 LMNA (0.39) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9517183 0.79 LMNA (0.38) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9517212 0.78 P4HTM (0.43) POLBNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed